Natural Alternatives International Incの主要な財務諸表は何ですか?
最新の財務諸表(Form-10K)によると、Natural Alternatives International Incの総資産は$151で、純損失は$-13です。
NAIIの主要な財務比率は何ですか?
Natural Alternatives International Incの流動比率は1.81、純利益率は-10.07、1株当たり売上高は$21.69です。
Natural Alternatives International Incの収益はセグメントまたは地域別にどのように分けられていますか?
Natural Alternatives International Inc の最大収益セグメントは Private-label Contract Manufacturing で、最新の利益発表における収益は 105,358,000 です。地域別に見ると、United States が Natural Alternatives International Inc の主要市場であり、収益は 73,512,000 です。
Natural Alternatives International Incは収益を上げていますか?
いいえ、最新の財務諸表によると、Natural Alternatives International Incの純損失は$-13です。
Natural Alternatives International Incに負債はありますか?
はい、Natural Alternatives International Incの負債は83です。
Natural Alternatives International Incの発行済株式数は何株ですか?
Natural Alternatives International Incの総発行済株式数は6.17株です。
主要データ
前終値
$2.68
始値
$2.67
当日レンジ
$2.64 - $2.72
52週レンジ
$2.33 - $4.96
取引高
13.0K
平均取引高
23.7K
配当利回り
--
1株当たり利益(TTM)
-2.43
時価総額
$16.5M
NAIIとは何ですか?
Natural Alternatives International, Inc. engages in the manufacturing, distribution, and marketing of nutritional supplements and other health care products. The company is headquartered in Carlsbad, California and currently employs 293 full-time employees. Its primary business activity is to provide private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbs, and other nutritional supplements, as well as other health care products, to consumers both within and outside the United States. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer ecommerce channels, and retail stores. The company manufactures products in a variety of forms, including capsules, tablets, chewable wafers, and powders to accommodate a variety of its customer’s preferences. The company also seeks to commercialize its patent and trademarks through the direct distribution and sale of CarnoSyn, SR CarnoSyn, TriBsyn, new contract manufacturing opportunities, and various license, royalty, and similar arrangements.